Develo
Summary active Updated Apr 30, 2026This profile is AI-generated. If you spot an error, please help us fix it by sharing a URL to the correct information.
Founders
About
Develo is a Los Angeles-based healthcare software startup founded in 2022 by Aaron Sin (CEO) and Han Ke that builds an AI-native, FHIR-conformant electronic medical records (EMR) platform purpose-built for independent pediatric practices 12. The platform manages scheduling, charting, billing, and family engagement, with automated bi-directional outreach to capture patient information 2. According to a SEC Form D filing dated March 4, 2026, Develo raised $13,999,989 in an exempt offering, with Aaron Sin listed as Chief Executive Officer 3. Tracxn classifies the round as Develo’s Series A, dated February 4, 2026 2. Prior backers include Fractal Software, z21 Ventures, and StartX 12.
Funding History
| Date | Round | Amount | Lead | Co-investors |
|---|---|---|---|---|
| 2026-03-04 | Series A | $14M | 23 | |
| 2023-10-03 | Seed | Fractal Software, z21 Ventures, StartX 12 |
What Investors Say
No independently sourced investor quotes found.
What Founders Say
No independently sourced founder quotes found.
Sources
-
Crunchbase, “Develo - Crunchbase Company Profile & Funding,” accessed April 2026. https://www.crunchbase.com/organization/develo-6603↩↩↩
-
Tracxn, “Develo - 2026 Funding Rounds & List of Investors,” accessed April 2026. https://tracxn.com/d/companies/develo/__cCd7ugKK3RCQuRTrjSrPwpO7Nj0Ukr8tAs5-MfZtLQ4/funding-and-investors↩↩↩↩↩↩
-
Intelligence360, “Develo has filed a notice of an exempt offering of securities to raise $13,999,989.00 in New Funding,” March 2026. Accessed April 2026. https://www.intelligence360.news/develo-has-filed-a-notice-of-an-exempt-offering-of-securities-to-raise-13999989-00-in-new-funding/↩↩